All corrections
LessWrong March 17, 2026 at 02:59 AM

www.lesswrong.com/posts/zXq7dpyj2ik9GcR5t/my-model-of-gender-identity

2 corrections found

1
Claim
children with CAH nonetheless have higher rates of identifying as men than the full XX population – roughly 10%, as opposed to ~0.3% in America at roughly the time the review was conducted.
Correction

The cited review does not report that about 10% of XX people with CAH simply 'identify as men.' Its 10.1% figure is for patients who were raised male, while the review separately reports 9% declared gender dysphoria and notes many cases were gender-fluid rather than a formal male identity.

Full reasoning

The number in the post does not match what the cited review actually says.

The review's abstract reports two different findings:

  • "Declared GD among 46,XX CAH patients attained 9% of the reported cohorts".
  • "Male gender raised patients (MGR) were 10.1% of CAH cohorts included in this review".

Those are not the same thing. The 10.1% figure is the share of reviewed patients who were raised male, often in contexts of late diagnosis and family choice — not a measured rate of all XX CAH patients later "identifying as men." The same abstract also says many CAH patients with gender dysphoria describe themselves as gender-fluid and do not seek formal transition, so equating the review to a simple "~10% identify as men" overstates and misstates the result.

A later systematic review/meta-analysis also broke this out by rearing sex rather than giving a blanket "~10% identify as men" figure: CAH reared females had 4% GID, while CAH reared males had 15%.

So the post's wording collapses several different outcomes into one and assigns the review a cleaner "~10% identify as men" result than it actually reports.

2 sources
2
Claim
this study and its correction strongly imply that such things don’t actually cause the median trans person to consume any less psychiatric medicine compared to those whose dysphoria goes untreated.
Correction

The cited paper and correction do not show that gender-affirming medical care in general fails to reduce psychiatric medication use relative to untreated dysphoria. The original study only tested associations with hormones and surgery inside a diagnosed Swedish cohort, and the correction says the reanalysis showed no advantage of surgery in that retrospective comparison.

Full reasoning

This sentence overstates what the cited study and correction actually examined.

The original paper was not a broad test of whether "gender-affirming medical care" as a whole reduces psychiatric medication use compared with untreated dysphoria. It analyzed a Swedish population with a gender incongruence diagnosis and asked whether 2015 mental-health treatment varied with time since hormone treatment or time since surgery. In that paper's abstract:

  • Years since initiating hormone treatment was not significantly related to likelihood of mental health treatment.
  • The now-corrected association concerned time since last gender-affirming surgery.

The correction then said the retrospective reanalysis showed "no advantage of surgery" on subsequent mood/anxiety-related visits, prescriptions, or suicide-attempt hospitalizations in that comparison. But that is still a statement about surgery, not all gender-affirming medical care. And the corrected comparison was between people diagnosed with gender incongruence who had received surgery and those diagnosed with gender incongruence who had not — not a clean comparison against people whose dysphoria simply "goes untreated."

So the post turns a much narrower result about a retrospective surgery comparison inside a diagnosed cohort into a much broader claim about medical care in general, the median trans person, and untreated dysphoria. The cited sources do not support that broader statement.

2 sources
Model: OPENAI_GPT_5 Prompt: v1.16.0